Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Sanson

Showing results (141-150 of 290) with videos related to

Pageof 29
Sort By:
Neuro-Oncology|November 20, 2012
Association between glioma susceptibility loci and tumour pathology defines specific molecular etiologiesAnna Luisa Di Stefano, Victor Enciso-Mora, Yannick Marie, et al.
Biomed Research International|May 29, 2014
Tumor and endothelial cell hybrids participate in glioblastoma vasculatureSoufiane El Hallani, Carole Colin, Younas El Houfi, et al.
Journal of Neuro-Oncology|March 18, 2018
Correction to: ATP binding cassette (ABC) transporters: expression and clinical value in glioblastomaAntonin Dréan, Shai Rosenberg, François-Xavier Lejeune, et al.
Journal of Neuro-Oncology|April 26, 2011
Prognostic stratification of gliomatosis cerebri by IDH1 R132H and INA expressionVirginie Desestret, Pietro Ciccarino, François Ducray, et al.
Histopathology|February 17, 2012
Prognostic value of Ki67 index in anaplastic oligodendroglial tumours--a translational study of the European Organization for Research and Treatment of Cancer Brain Tumor GroupMatthias Preusser, Romana Hoeftberger, Adelheid Woehrer, et al.
Cancer|August 21, 2014
Diagnostic and prognostic value of preoperative combined GFAP, IGFBP-2, and YKL-40 plasma levels in patients with glioblastomaJaime Gállego Pérez-Larraya, Sophie Paris, Ahmed Idbaih, et al.
Neuro-Oncology|February 8, 2021
Role of 3D volume growth rate for drug activity evaluation in meningioma clinical trials: the example of the CEVOREM studyThomas Graillon, Loic Ferrer, Jason Siffre, et al.
Cancer Discovery|September 23, 2021
Futibatinib, an Irreversible FGFR1-4 Inhibitor, in Patients with Advanced Solid Tumors Harboring <i>FGF</i>/<i>FGFR</i> Aberrations: A Phase I Dose-Expansion StudyFunda Meric-Bernstam, Rastislav Bahleda, Cinta Hierro, et al.
Molecular Cancer|May 22, 2008
Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profileFrançois Ducray, Ahmed Idbaih, Aurélien de Reyniès, et al.
Journal of Neuro-Oncology|July 12, 2008
Genomic changes in progression of low-grade gliomasAhmed Idbaih, Rosana Carvalho Silva, Emmanuelle Crinière, et al.
Pageof 29

Showing results (141-150 of 290) with videos related to

Sort By:
Pageof 29
Neuro-Oncology|November 20, 2012
Association between glioma susceptibility loci and tumour pathology defines specific molecular etiologiesAnna Luisa Di Stefano, Victor Enciso-Mora, Yannick Marie, et al.
Biomed Research International|May 29, 2014
Tumor and endothelial cell hybrids participate in glioblastoma vasculatureSoufiane El Hallani, Carole Colin, Younas El Houfi, et al.
Journal of Neuro-Oncology|March 18, 2018
Correction to: ATP binding cassette (ABC) transporters: expression and clinical value in glioblastomaAntonin Dréan, Shai Rosenberg, François-Xavier Lejeune, et al.
Journal of Neuro-Oncology|April 26, 2011
Prognostic stratification of gliomatosis cerebri by IDH1 R132H and INA expressionVirginie Desestret, Pietro Ciccarino, François Ducray, et al.
Histopathology|February 17, 2012
Prognostic value of Ki67 index in anaplastic oligodendroglial tumours--a translational study of the European Organization for Research and Treatment of Cancer Brain Tumor GroupMatthias Preusser, Romana Hoeftberger, Adelheid Woehrer, et al.
Cancer|August 21, 2014
Diagnostic and prognostic value of preoperative combined GFAP, IGFBP-2, and YKL-40 plasma levels in patients with glioblastomaJaime Gállego Pérez-Larraya, Sophie Paris, Ahmed Idbaih, et al.
Neuro-Oncology|February 8, 2021
Role of 3D volume growth rate for drug activity evaluation in meningioma clinical trials: the example of the CEVOREM studyThomas Graillon, Loic Ferrer, Jason Siffre, et al.
Cancer Discovery|September 23, 2021
Futibatinib, an Irreversible FGFR1-4 Inhibitor, in Patients with Advanced Solid Tumors Harboring <i>FGF</i>/<i>FGFR</i> Aberrations: A Phase I Dose-Expansion StudyFunda Meric-Bernstam, Rastislav Bahleda, Cinta Hierro, et al.
Molecular Cancer|May 22, 2008
Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profileFrançois Ducray, Ahmed Idbaih, Aurélien de Reyniès, et al.
Journal of Neuro-Oncology|July 12, 2008
Genomic changes in progression of low-grade gliomasAhmed Idbaih, Rosana Carvalho Silva, Emmanuelle Crinière, et al.
Pageof 29